BevacizumabIntraocular inflammation following intravitreal administration: 9 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2010年 / 1312卷 / 1期

关键词：

Visual Acuity; Bevacizumab; Myopia; Macular Degeneration; Diabetic Macular Oedema;

D O I：

10.2165/00128415-201013120-00044

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：13 / 13

相关论文

共 50 条

[1] BevacizumabIntraocular inflammation following intravitreal administration: case report
Reactions Weekly, 2011, 1340 (1) : 12 - 12
[2] BevacizumabIntraocular inflammation in patients receiving intravitreal therapy: 5 case reports
Reactions Weekly, 2010, 1300 (1) : 11 - 11
[3] BevacizumabIntraocular inflammation: 8 case reports
Reactions Weekly, 2009, 1255 (1) : 10 - 10
[4] Bevacizumab/ranibizumabBacterial endophthalmitis and acute intraocular inflammation following intravitreal administration: 9 case reports
Reactions Weekly, 2010, 1316 (1) : 12 - 12
[5] Bevacizumab/ranibizumabIntraocular inflammation following intravitreal administration: 4 case reports
Reactions Weekly, 2010, 1330 (1) : 11 - 11
[6] BevacizumabUveitis following intravitreal administration: 6 case reports
Reactions Weekly, 2011, 1377 (1) : 11 - 11
[7] MethotrexateKeratitis following intravitreal administration: 2 case reports
Reactions Weekly, 2013, 1444 (1) : 26 - 26
[8] BevacizumabEndophthalmitis following intravitreal administration: 5 case reports
Reactions Weekly, 2011, 1380 (1) : 9 - 10
[9] TriamcinoloneBlepharoptosis following intravitreal administration: 4 case reports
Reactions Weekly, 2007, 1176 (1) : 30 - 31
[10] TriamcinoloneGlaucoma following intravitreal administration: 3 case reports
Reactions Weekly, 2007, 1178 (1) : 34 - 34

← 1 2 3 4 5 →